International Clinical Trial: Ex Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory Bowel Disease

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824726) titled 'Ex Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory Bowel Disease' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: PhoenixLAB srls

Condition: Ulcerative Colitis (UC) IBD (Inflammatory Bowel Disease) Crohn Disease (CD)

Intervention: Procedure: Collection of 8 additional intestinal mucosal biopsies during standard-of-care endoscopy for subsequent ex vivo testing

Recruitment Stat...